PUBLISHER: The Business Research Company | PRODUCT CODE: 2127583
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127583
Reusable minimally invasive surgical instruments are specialized medical tools developed for use in minimally invasive surgical (MIS) procedures and are designed to be sterilized and reused multiple times after each operation. These instruments are typically manufactured from durable materials such as stainless steel, titanium, or high-performance polymers to withstand repeated cleaning, disinfection, and sterilization processes. The primary purpose of reusable minimally invasive surgical instruments is to support surgeons in performing precise surgical procedures with minimal damage to surrounding tissues while lowering overall healthcare costs through repeated utilization.
The primary product types of reusable minimally invasive surgical instruments include scissors, forceps, needles, electrosurgical devices, light sources, retractors, and other product types. Scissors refer to reusable surgical cutting instruments designed for precise tissue dissection and surgical procedures during minimally invasive operations. These products are manufactured using material types such as stainless steel, plastics, alloys, carbon fiber, and other composite materials and are distributed through direct sales, distributors, online sales, retail pharmacies, and medical equipment suppliers. The various application areas include cardiovascular surgery, orthopedic surgery, gynecological surgery, general surgery, urological surgery, gastrointestinal surgery, and others, and they are used by end users such as hospitals, surgical centers, ambulatory surgical centers, specialized clinics, and research institutions.
Tariffs are influencing the reusable minimally invasive surgical instruments market by increasing the cost of imported stainless steel, titanium alloys, carbon fiber materials, precision components, and surgical manufacturing equipment required for instrument production. The impact is most significant on electrosurgical devices, light sources, forceps, and reusable endoscopic hand instruments, while hospitals and surgical centers are facing higher procurement and maintenance costs. Regions heavily dependent on imported medical-grade materials and surgical device components, particularly Asia-Pacific, Europe, and North America, are experiencing supply chain disruptions and pricing pressures. However, tariffs are also promoting domestic manufacturing expansion, localized sourcing strategies, and investment in regional medical device production ecosystems, strengthening long-term supply chain resilience and market competitiveness.
The reusable minimally invasive surgical instruments market research report is one of a series of new reports from The Business Research Company that provides reusable minimally invasive surgical instruments market statistics, including reusable minimally invasive surgical instruments industry global market size, regional shares, competitors with a reusable minimally invasive surgical instruments market share, detailed reusable minimally invasive surgical instruments market segments, market trends and opportunities, and any further data you may need to thrive in the reusable minimally invasive surgical instruments industry. This reusable minimally invasive surgical instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The reusable minimally invasive surgical instruments market size has grown strongly in recent years. It will grow from $2.39 billion in 2025 to $2.6 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing volume of minimally invasive surgical procedures, growing demand for cost effective surgical solutions, advancements in surgical instrument material technologies, expansion of healthcare infrastructure and surgical facilities, rising adoption of laparoscopic and endoscopic techniques.
The reusable minimally invasive surgical instruments market size is expected to see strong growth in the next few years. It will grow to $3.68 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to growing demand for reusable healthcare equipment, increasing number of outpatient surgical procedures, expansion of specialized surgical centers worldwide, rising investments in advanced surgical technologies, growing focus on reducing medical waste and operational costs. Major trends in the forecast period include growing adoption of reusable surgical instruments to reduce procedural costs, increasing preference for high durability stainless steel surgical instruments, rising demand for advanced sterilization compatible instrument designs, expansion of minimally invasive surgical procedures across healthcare facilities, development of ergonomic surgical instruments for improved surgeon precision.
The growing adoption of minimally invasive surgical procedures is expected to drive the growth of the reusable minimally invasive surgical instruments market going forward. Minimally invasive surgical procedures are advanced surgical techniques that involve smaller incisions, imaging assistance, and specialized instruments to perform procedures with reduced tissue trauma, lower complication risks, and faster recovery times. The adoption of these procedures is increasing due to advancements in medical technology, enhanced anesthesia methods, and healthcare systems focusing on shorter hospital stays, lower healthcare expenses, and improved surgical efficiency. Reusable minimally invasive surgical instruments support these procedures by offering cost-effective, precision-oriented, and sterilizable tools, including forceps, scissors, graspers, and retractors, that can be reused across multiple surgeries while maintaining accuracy and operational effectiveness. For instance, in February 2024, according to the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, approximately 83% of medical procedures performed in 2023 were minimally invasive, while conventional surgical procedures accounted for the remaining 17%. Additionally, in 2023, according to the American Society of Plastic Surgeons, a US-based specialty organization, the number of cosmetic minimally invasive procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Therefore, the increasing adoption of minimally invasive surgical procedures is supporting the growth of the reusable minimally invasive surgical instruments market.
Major companies operating in the reusable minimally invasive surgical instruments market are focusing on product advancements, including flexible reusable ureteroscope systems, to improve visualization, enable better access to complex urinary tract anatomy, and enhance procedural precision in urological surgeries. Flexible reusable ureteroscopes are advanced endoscopic devices designed for minimally invasive diagnosis and treatment of conditions affecting the kidney and urinary tract, providing superior maneuverability, improved imaging capabilities, and the ability to undergo sterilization for repeated procedures. For instance, in February 2026, Stryker, a US-based medical technology company specializing in surgical equipment and endoscopic systems, launched the F88 Flexible Ureteroscope, a minimally invasive surgical instrument. The newly introduced reusable flexible ureteroscope is designed to strengthen Stryker's urology portfolio by facilitating improved anatomical access through enhanced deflection capabilities and advanced imaging performance, supporting minimally invasive treatment of kidney stones and other urological disorders.
In August 2024, KARL STORZ, a Germany-based medical technology company, acquired Asensus Surgical for $95 million. Through this acquisition, KARL STORZ aimed to strengthen its robotic-assisted and minimally invasive surgery portfolio by integrating Asensus Surgical's Performance-Guided Surgery technologies, digital laparoscopy capabilities, and next-generation LUNA robotic platform to expand its presence in the growing surgical robotics market. Asensus Surgical is a US-based medical device company that develops robotic-assisted and reusable minimally invasive surgical technologies for laparoscopic procedures.
Major companies operating in the reusable minimally invasive surgical instruments market report are Stryker Corporation, Medtronic plc, Johnson & Johnson, B. Braun SE, Olympus Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, CONMED Corporation, Zimmer Biomet, Smith & Nephew, Teleflex Incorporated, Becton Dickinson and Company, Arthrex, Applied Medical, Erbe Elektromedizin, KLS Martin Group, Intuitive Surgical, Getinge, Medicon eG, CooperSurgical, Encision Inc., Aspen Surgical Products
North America was the dominating region in the reusable minimally invasive surgical instruments market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the reusable minimally invasive surgical instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the reusable minimally invasive surgical instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The reusable minimally invasive surgical instruments market consists of sales of reusable trocars, reusable forceps, reusable scissors, reusable graspers, reusable retractors, reusable clip appliers, reusable suction and irrigation devices, reusable needle holders, and reusable electrosurgical instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Reusable Minimally Invasive Surgical Instruments Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses reusable minimally invasive surgical instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for reusable minimally invasive surgical instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The reusable minimally invasive surgical instruments market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.